- $9.94bn
- $11.96bn
- $2.96bn
- 69
- 19
- 49
- 42
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 22.52 | ||
PEG Ratio (f) | 1.75 | ||
EPS Growth (f) | 14.81% | ||
Dividend Yield (f) | 0.31% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 5.56 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 59.13 | ||
Price to Sales | 3.19 | ||
EV to EBITDA | 19.66 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 10.11% | ||
Return on Equity | 23.31% | ||
Operating Margin | 14.9% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 2,072.6 | 1,987.5 | 2,417.9 | 2,530.7 | 2,964.5 | 3,402.22 | 3,717.76 | 9.36% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +7.36 | -13.29 | +67.26 | +12.03 | +13.37 | +8.25 | +17.32 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It also offers advanced research Raman microscopy systems. Its product lines include nCounter, CosMx, GeoMx and AtoMx.
Directors
- Frank Laukien CHM (61)
- Gerald Herman CFO (63)
- Falko Busse CEX (54)
- Burkhard Prause CEX (54)
- Juergen Srega CEX (66)
- Mark Munch EVP (59)
- William Linton LED (73)
- Bonnie Anderson IND (63)
- Cynthia Friend IND (66)
- Marc Kastner IND (75)
- John Ornell IND (63)
- Richard Packer IND (63)
- Adelene Perkins IND (61)
- Hermann Requardt IND (65)
- Robert Rosenthal IND (64)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- February 4th, 2000
- Public Since
- August 4th, 2000
- No. of Shareholders
- 67
- No. of Employees
- 9,707
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 151,394,441
- Address
- 40 MANNING RD, BILLERICA, 01821
- Web
- https://www.bruker.com/
- Phone
- +1 9786633660
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for BRKR
Q4 2024 Bruker Corp Earnings Release
Similar to BRKR
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
As of Today at 20:11 UTC, shares in Bruker are trading at $65.66. This share price information is delayed by 15 minutes.
Shares in Bruker last closed at $65.66 and the price had moved by -2.65% over the past 365 days. In terms of relative price strength the Bruker share price has underperformed the S&P500 Index by -23% over the past year.
The overall consensus recommendation for Bruker is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Bruker dividend yield is 0.3% based on the trailing twelve month period.
Last year, Bruker paid a total dividend of $0.20, and it currently has a trailing dividend yield of 0.3%.Looking ahead, the next dividend pay date is 2024-09-16.
We do not have data on when Bruker is to next pay dividends. The historic dividend yield on Bruker shares is currently 0.3%.
To buy shares in Bruker you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $65.66, shares in Bruker had a market capitalisation of $9.94bn.
Here are the trading details for Bruker:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: BRKR
Based on an overall assessment of its quality, value and momentum Bruker is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Bruker is $77.01. That is 17.29% above the last closing price of $65.66.
Analysts covering Bruker currently have a consensus Earnings Per Share (EPS) forecast of $2.60 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bruker. Over the past six months, its share price has underperformed the S&P500 Index by -34.75%.
As of the last closing price of $65.66, shares in Bruker were trading -10.41% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bruker PE ratio based on its reported earnings over the past 12 months is 22.52. The shares last closed at $65.66.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bruker's management team is headed by:
- Frank Laukien - CHM
- Gerald Herman - CFO
- Falko Busse - CEX
- Burkhard Prause - CEX
- Juergen Srega - CEX
- Mark Munch - EVP
- William Linton - LED
- Bonnie Anderson - IND
- Cynthia Friend - IND
- Marc Kastner - IND
- John Ornell - IND
- Richard Packer - IND
- Adelene Perkins - IND
- Hermann Requardt - IND
- Robert Rosenthal - IND